1. Home
  2. CFFI vs ENTA Comparison

CFFI vs ENTA Comparison

Compare CFFI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C&F Financial Corporation

CFFI

C&F Financial Corporation

N/A

Current Price

$109.74

Market Cap

298.3M

Sector

Finance

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$11.08

Market Cap

339.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
ENTA
Founded
1927
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
298.3M
339.0M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
CFFI
ENTA
Price
$109.74
$11.08
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $21.83
AVG Volume (30 Days)
51.1K
★ 251.0K
Earning Date
10-26-2026
11-16-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
★ 37.94
29.93
EPS
★ 4.71
N/A
Revenue
★ $140,841,000.00
$102,814,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.45
N/A
P/E Ratio
$23.23
★ N/A
Revenue Growth
10.63
★ 16.48
52 Week Low
$66.48
$10.22
52 Week High
$110.52
$17.15

Technical Indicators

Market Signals
Indicator
CFFI
ENTA
Relative Strength Index (RSI) 72.87 40.79
Support Level $70.30 $10.90
Resistance Level N/A $13.94
Average True Range (ATR) 2.80 0.66
MACD 0.35 0.02
Stochastic Oscillator 78.80 25.19

Price Performance

Historical Comparison
CFFI
ENTA

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: